Literature DB >> 20556199

Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.

James P Hamilton1.   

Abstract

Primary tumors of the liver and biliary tree are increasing in frequency and portend a miserable prognosis. Epigenetic regulation of gene expression has emerged as a fundamental aspect of cancer development and progression. The molecular mechanisms of carcinogenesis in hepatocellular carcinoma and cholangiocarcinoma involve a complex interplay of both genetic and epigenetic factors. Recent studies investigating the possible epigenetic mechanisms induced in the disease have shed new light on the molecular underpinnings of hepatobiliary cancers. In addition, epigenetic modifications of DNA in cancer and precancerous lesions offer hope and the promise of novel biomarkers for early cancer detection, prediction, prognosis and response to treatment. Furthermore, the reversal of epigenetic changes represents a potential target for novel therapeutic strategies and medication design.

Entities:  

Year:  2010        PMID: 20556199      PMCID: PMC2884160          DOI: 10.2217/epi.10.9

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  81 in total

Review 1.  Transposons reanimated in mice.

Authors:  Timothy H Bestor
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

2.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

3.  Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.

Authors:  Pippa Newell; Sara Toffanin; Augusto Villanueva; Derek Y Chiang; Beatriz Minguez; Laia Cabellos; Radoslav Savic; Yujin Hoshida; Kiat Hon Lim; Pedro Melgar-Lesmes; Steven Yea; Judit Peix; Kemal Deniz; M Isabel Fiel; Swan Thung; Clara Alsinet; Victoria Tovar; Vincenzo Mazzaferro; Jordi Bruix; Sasan Roayaie; Myron Schwartz; Scott L Friedman; Josep M Llovet
Journal:  J Hepatol       Date:  2009-06-12       Impact factor: 25.083

4.  Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver.

Authors:  Jan Harder; Oliver G Opitz; Jan Brabender; Manfred Olschewski; Hubert E Blum; Shuji Nomoto; Henning Usadel
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

5.  [Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma].

Authors:  Guo-li Lü; Jian-ming Wen; Jian-min Xu; Meng Zhang; Ruo-bing Xu; Bao-ling Tian
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2003-06

6.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 7.  Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.

Authors:  Ying Ying; Qian Tao
Journal:  Epigenetics       Date:  2009-07-25       Impact factor: 4.528

8.  Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.

Authors:  Pei-Fen Su; Te-Chang Lee; Pei-Ju Lin; Po-Huang Lee; Yung-Ming Jeng; Chien-Hung Chen; Ja-Der Liang; Ling-Ling Chiou; Guan-Tarn Huang; Hsuan-Shu Lee
Journal:  Int J Cancer       Date:  2007-09-15       Impact factor: 7.396

9.  Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.

Authors:  Mohammad Obaidul Hoque; Shahnaz Begum; Mariana Brait; Carmen Jeronimo; Marianna Zahurak; Kimberly Laskie Ostrow; Eli Rosenbaum; Bruce Trock; William H Westra; Mark Schoenberg; Steven N Goodman; David Sidransky
Journal:  J Urol       Date:  2007-12-20       Impact factor: 7.450

Review 10.  Molecular and functional genetics of hepatocellular carcinoma.

Authors:  Judy Wai Ping Yam; Chun Ming Wong; Irene Oi-Lin Ng
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
View more
  7 in total

Review 1.  Epigenetics: principles and practice.

Authors:  James P Hamilton
Journal:  Dig Dis       Date:  2011-07-05       Impact factor: 2.404

2.  From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

Authors:  Marion Martin; Zdenko Herceg
Journal:  Genome Med       Date:  2012-01-31       Impact factor: 11.117

Review 3.  Epigenetic events in liver cancer resulting from alcoholic liver disease.

Authors:  Samuel W French
Journal:  Alcohol Res       Date:  2013

4.  Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.

Authors:  Jihua Nie; Jingying Zhang; Lili Wang; Lunjie Lu; Qian Yuan; Fangmei An; Shuyu Zhang; Yang Jiao
Journal:  J Exp Clin Cancer Res       Date:  2017-12-13

Review 5.  Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.

Authors:  Kun Jiang; Barbara A Centeno
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

6.  Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.

Authors:  Kun Jiang; Sameer Al-Diffhala; Barbara A Centeno
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

Review 7.  Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review.

Authors:  Maisa Mahmoud Ali Kamkar; Rasheed Ahmad; Osama Alsmadi; Kazem Behbehani
Journal:  J Diabetes Metab Disord       Date:  2014-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.